Proscia, a leading provider of digital and computational pathology solutions, has announced that the Joint Pathology Center (JPC), the premiere pathology reference unit for the US government, has selected Proscia’s Concentriq platform.
At the centre of this modernisation effort, JPC will digitise its tissue archive, the world’s largest repository of human pathology specimen, to capitalise on this invaluable source of medical data. The digital repository will provide increased access to data for driving medical advances related to infectious diseases and cancer, as well as accelerate the development of computational pathology applications establishing diagnosis, prognosis and personalised therapies for patients.
As digitising the world’s largest human tissue archive depends on scalable software infrastructure, JPC has selected Proscia’s Concentriq digital and computational pathology platform to provide this foundation. Concentriq is a singular image and data management platform that unifies pathology operations across the connected enterprise and accelerates workflows. With Concentriq, JPC will provide its network of researchers with intuitive, secure access to its data and streamline collaboration, enabling them to more easily analyse thousands of diseases and find new ways to fight them.
Additionally, JPC will deploy Concentriq to digitise its routine pathology consultations and overcome the delays that result from sharing physical specimen in an effort to improve patient outcomes by providing accurate, timely pathology findings.
Digitising the repository also holds significant potential for advancing the development of computational pathology applications spanning diagnosis, prognosis and personalised care. Training and validating even a single application requires massive numbers of images to ensure that it can account for the variability seen in practice, and JPC’s archive is unmatched in its ability to provide these data for countless diseases and cases. As JPC delivers these applications, it can deploy them, along with other computational solutions, into its research and clinical workflows.
“JPC’s modernisation effort marks a monumental leap forward for the field of pathology, and we’re excited to be a part of it,” said David West (Proscia CEO). “Concentriq sits at the intersection of digital and computational pathology across research and clinical practice, providing JPC with the tools needed to finally realise the full promise of its data and transform routine diagnosis.”
